$Orthofix designs, develops, manufactures, markets and distributes inspired and innovative medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. Our main products are noninvasive stimulation products used to enhance the success rate of spinal fusions and to treat nonunion fractures, external and internal fixation devices used in fracture treatment, limb lengthening and bone reconstruction, and bracing products used for ligament injury prevention, pain management and protection of surgical repair to promote faster healing. Orthofix products also include a device for enhancing venous circulation, cold therapy, other pain management products, bone cement and devices for removal of the bone cement used to fix artificial implants and airway management products used in anesthesia applications. Our products are designed and realized to fulfill the particular needs of both patient and clinician. Care and commitment are the keystones of our success.$

Orthofix International Announces 2nd Quarter 2008 Results. (more)

Orthofix International Signs Development and Commercialization Agreements with Musculoskeletal Transplant Foundation. (more)

Orthofix International Announces Earnings Release Date for 2nd Quarter 2008. (more)

Orthofix International Promotes Brad Mason to Group President, North America. (more)

Maria Sainz Elected to Orthofix International Board of Directors. (more)

See Orthofix Courses and
Seminars (more) and Events and Congresses (more).

Harnessing the potential of a child's growth plate to correct angular deformities.
(Info for Parents & Doctors)

The only proven safe and effective bone growth stimulator for high-risk cervical fusion.
(More)